CBNAAT: A Boon for Early Diagnosis of Tuberculosis-Head and Neck

  • Kavita Sachdeva
  • Tanvi Shrivastava
Original Article


Tuberculosis of head and neck has been an under diagnosed entity due to large number of smear negative cases, which results in missing out the positive cases, further increasing the burden of TB. The role of cartridge- based nucleic acid amplification test (CBNAAT) with a potential to diagnose TB and rifampicin resistance within 2 h is promising. The study highlights the extended implications of CBNAAT in infectious lesions of head and neck, where the pus or aspirate was subjected to this test, along with other investigations which have been routinely used for detection of extra pulmonary tuberculosis. Twelve patients with infective lesions of head and neck were included in this prospective study, conducted in Department of Otorhinolaryngology, Netaji Subhash Chandra Bose Medical College and hospital, Jabalpur from September 2016 to March 2017. They were investigated for pulmonary and extra pulmonary TB. CBNAAT, microscopy, FNAC and HPR from the site of lesion were done. Nine out of twelve patients were diagnosed positive for Tuberculosis. Microscopy (ZN staining) could detect only two such cases, whereas FNAC showed granulomatous lesion in 3 cases (33.3%). CBNAAT was positive in 77.7% of the total positive cases. Histopathological examination showed 100% results but was feasible only in selected number of cases (4 in this study). CBNAAT provides a promising role in early diagnosis of TB in head and neck. Its high sensitivity and less time taking procedure makes it an excellent tool for timely diagnosis of such cases.


CBNAAT Extra-pulmonary TB Head and neck TB GeneXpert MTB/RIF 


Compliance with Ethical Standards

Conflict of interest

The authors have no conflict of interest. The CBNAAT test was done free of cost at the ICMR microbiology laboratory (endorsed by WHO-2010), Jabalpur with the permission of the Director of ICMR, Jabalpur; with no conflict of interests.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all individual participants included in the study.


  1. 1.
    Helb D et al (2010) Rapid detection of mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol 48:229–237CrossRefPubMedGoogle Scholar
  2. 2.
    Hopewell PC, Small PM (1994) Tuberculosis and nontuberculous mycobacterial infections. In: Stein JH (ed) Internal medicine, 4th edn. Mosby, St Louis, pp 2193–2212Google Scholar
  3. 3.
    Das DK (2000) Fine-needle aspiration cytology in the diagnosis of tuberculous lesions. Lab Med 31(11):625–632CrossRefGoogle Scholar
  4. 4.
    World Health Organization (2013) Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system for the diagnosis of pulmonary and extrapulmonary TB in adults and children: policy update. World Health Organization, GenevaGoogle Scholar
  5. 5.
    World Health Organization (2014) Xpert MTB/RIF implementation manual: technical and operational ‘how-to’; practical considerations. ISBN: 978 92 4 150670 0 (NLM classi cation: WF 310) World Health OrganizationGoogle Scholar
  6. 6.
    Bruzgielewicz A, Rzepakowska A, Osuch-Wójcikewicz E et al (2014) Tuberculosis of the head and neck—epidemiological and clinical presentation. Arch Med Sci 10(6):1160–1166CrossRefPubMedGoogle Scholar
  7. 7.
    Nalini B, Subramaniam V (2006) Tuberculosis in ear, nose and throat practice: its presentation and diagnosis. Am J Otolaryngol 27:39–45CrossRefPubMedGoogle Scholar
  8. 8.
    World Health Organization (2013) Definitions and reporting framework for tuberculosis—2013 revision. World Health Organization, Geneva (WHO/HTM/TB/2013.2). available at http://Google Scholar
  9. 9.
    Penfold CN, Revington PJ (1996) A review of 23 patients with tuberculosis of head and neck. Br J Oral Maxillof Surg 34:508–510CrossRefGoogle Scholar
  10. 10.
    Sanjay A, Satyadeo C, Satyendra M, Atul K (2016) To study the usefulness of CBNAAT (cartridge based nuclear acid amplification test) in BAL (bronchoalveolar lavage) samples in the diagnosis of smear-negative/non sputum producing patients with suspected tuberculosis. J Evol Med Dent Sci/eISSN- 2278-4802, pISSN- 2278-4748/Vol. 5/Issue 01Google Scholar
  11. 11.
    Dewan R, Anuradha S, Khanna A et al (2015) Role of cartridge-based nucleic acid amplification test (CBNAAT) for early diagnosis of pulmonary tuberculosis in HIV. JIACM 16(2):114–117Google Scholar
  12. 12.
    Lawn SD, Zumla AI (2012) Diagnosis of extrapulmonary tuberculosis using the Xpert® MTB/RIF assay. Expert Rev Anti Infect Ther 10(6):631–635CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Sowjanya DS, Behera G, Ramana Reddy VV (2014) CBNAAT: a novel diagnostic tool for rapid and specific detection of mycobacterium tuberculosis in pulmonary sample. Int J Health Res Modern Integr Med Sci (IJHRMIMS), ISSN 2394-8612 (P), ISSN 2394-8620 (O)Google Scholar

Copyright information

© Association of Otolaryngologists of India 2018

Authors and Affiliations

  1. 1.Department of OtorhinolaryngologyNSCB Medical College and HospitalJabalpurIndia

Personalised recommendations